Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person15
Lexaria Bioscience Corp.
Company
Twist Bioscience Corp
Company
Legence Corp.
Company
Bio Essence Corp
Company
Cogent Biosciences, Inc.
Company
PURE BIOSCIENCE, INC.
Company
Skye Bioscience, Inc.
Company
Caribou Biosciences, Inc.
Company
Dare Bioscience, Inc.
Company
Yarrow Bioscience, Inc.
Company
Cytek Biosciences, Inc.
Company
Niagen Bioscience, Inc.
Company
SPRUCE BIOSCIENCES, INC.
Company
CASTLE BIOSCIENCES INC
Company
HARVARD BIOSCIENCE INC
Company
Primary record4
Lexaria Bioscience Corp. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On September 7, 2026, Lexaria Bioscience Corp. (the "Company") entered into inducement offer letter agreements (each, an "Inducement Letter") with certain holders (ea
Lexaria Bioscience Corp. filed 8-K
Item 8.01 Other Events Receipt of Australian R & D Tax Incentive Credit On August 28, 2026, Lexaria (AU) Pty Ltd, the wholly-owned subsidiary of Lexaria Bioscience Corp. which holds the exclusive rights to use DehydraTEC
Lexaria Bioscience Corp. filed 8-K
Item 8.01 Other Events Cure of Nasdaq Bid Price Deficiency On August 17, 2026, Lexaria Bioscience Corp. (the Company ) received a letter from the Hearings Advisor of The Nasdaq Stock Market ( Nasdaq ) advising that the N
Lexaria Bioscience Corp. filed 8-K
Item 3.01 Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer of Listing Nasdaq Delisting Notification On August 4, 2026 Lexaria Bioscience Corp. (the “Company”) received a notification